|
[1]
|
Amadi-Obi, A., Yu, C.R., Liu, X., Mahdi, R.M., Clarke, G.L., Nussenblatt, R.B., Gery, I., Lee, Y.S. and Egwuagu, C.E. (2007) TH17 Cells Contribute to Uveitis and Scleritis and Are Expanded by IL-2 and Inhibited by IL-27/STAT1. Nature Medicine, 13, 711-718.
[Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Oh, H.M., Yu, C.R., Lee, Y., Chan, C.C., Maminishkis, A. and Egwuagu, C.E. (2011) Autoreactive Memory CD4+ T Lymphocytes That Mediate Chronic Uveitis Reside in the Bone Marrow through STAT3-Dependent Mechanisms. The Journal of Immunology, 187, 3338-3346.
[Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Takeuchi, M. (2013) A Systematic Review of Biologics for the Treatment of Noninfectious Uveitis. Immunotherapy-Uk, 5, 91-102.
[Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Podojil, J.R. and Miller, S.D. (2013) Targeting the B7 Family of Co-Stimulatory Molecules: Successes and Challenges. Biodrugs, 27, 1-13.
[Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Lechner, M.G., Russell, S.M., Bass, R.S. and Epstein, A.L. (2011) Chemokines, Costimulatory Molecules and Fusion Proteins for the Immunotherapy of Solid Tumors. Immunotherapy-Uk, 3, 1317-1340.
[Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Ford, M.L., Adams, A.B. and Pearson, T.C. (2014) Targeting Co-Stimulatory Pathways: Transplantation and Autoimmunity. Nature Reviews Nephrology, 10, 14-24.
[Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Trivedi, A. and Katelaris, C. (2019) The Use of Biologic Agents in the Management of Uveitis. Internal Medicine Journal, 49, 1352-1363.
[Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Bettelli, E., Korn, T. and Kuchroo, V.K. (2007) Th17: The Third Member of the Effector T Cell Trilogy. Current Opinion in Immunology, 19, 652-657.
[Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Ivanov, I.I., Zhou, L. and Littman, D.R. (2007) Transcriptional Regulation of Th17 Cell Differentiation. Seminars in Immunology, 19, 409-417.
[Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Liu, X., Lee, Y.S., Yu, C.R. and Egwuagu, C.E. (2008) Loss of STAT3 in CD4+ T Cells Prevents Development of Experimental Autoimmune Diseases. The Journal of Immunology, 180, 6070-6076.
[Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Yu, C.R., Lee, Y.S., Mahdi, R.M., Surendran, N. and Egwuagu, C.E. (2012) Therapeutic Targeting of STAT3 (Signal Transducers and Activators of Transcription 3) Pathway Inhibits Experimental Autoimmune Uveitis. PLoS ONE, 7, e29742.
[Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Solt, L.A., Kumar, N., Nuhant, P., Wang, Y., Lauer, J.L., Liu, J., Istrate, M.A., Kamenecka, T.M., Roush, W.R., Vidovic, D., Schurer, S.C., Xu, J., Wagoner, G., Drew, P.D., Griffin, P.R. and Burris, T.P. (2011) Suppression of TH17 Differentiation and Autoimmunity by a Synthetic ROR Ligand. Nature, 472, 491-494.
[Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Huh, J.R., Leung, M.W., Huang, P., Ryan, D.A., Krout, M.R., Malapaka, R.R., Chow, J., Manel, N., Ciofani, M., Kim, S.V., Cuesta, A., Santori, F.R., Lafaille, J.J., Xu, H.E., Gin, D.Y., Rastinejad, F. and Littman, D.R. (2011) Digoxin and Its Derivatives Suppress TH17 Cell Differentiation by Antagonizing RORgammat Activity. Nature, 472, 486-490.
[Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Greenhalgh, C.J. and Hilton, D.J. (2001) Negative Regulation of Cytokine Signaling. Journal of Leukocyte Biology, 70, 348-356.
|
|
[15]
|
Jo, D., Liu, D., Yao, S., Collins, R.D. and Hawiger, J. (2005) Intracellular Protein Therapy with SOCS3 Inhibits Inflammation and Apoptosis. Nature Medicine, 11, 892-898.
[Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Neuwirt, H., Puhr, M., Santer, F.R., Susani, M., Doppler, W., Marcias, G., Rauch, V., Brugger, M., Hobisch, A., Kenner, L. and Culig, Z. (2009) Suppressor of Cytokine Signaling (SOCS)-1 Is Expressed in Human Prostate Cancer and Exerts Growth-Inhibitory Function through Down-Regulation of Cyclins and Cyclin-Dependent Kinases. The American Journal of Pathology, 174, 1921-1930.
[Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Flowers, L.O., Johnson, H.M., Mujtaba, M.G., Ellis, M.R., Haider, S.M. and Subramaniam, P.S. (2004) Characterization of a Peptide Inhibitor of Janus Kinase 2 That Mimics Suppressor of Cytokine Signaling 1 Function. The Journal of Immunology, 172, 7510-7518.
[Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Waiboci, L.W., Ahmed, C.M., Mujtaba, M.G., Flowers, L.O., Martin, J.P., Haider, M.I. and Johnson, H.M. (2007) Both the Suppressor of Cytokine Signaling 1 (SOCS-1) Kinase Inhibitory Region and SOCS-1 Mimetic Bind to JAK2 Autophosphorylation Site: Implications for the Development of a SOCS-1 Antagonist. The Journal of Immunology, 178, 5058-5068.
[Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Ahmed, C.M., Dabelic, R., Martin, J.P., Jager, L.D., Haider, S.M. and Johnson, H.M. (2010) Enhancement of Antiviral Immunity by Small Molecule Antagonist of Suppressor of Cytokine Signaling. The Journal of Immunology, 185, 1103- 1113.
[Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Vignali, D.A. and Kuchroo, V.K. (2012) IL-12 Family Cytokines: Immunological Playmakers. Nature Immunology, 13, 722-728.
[Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Lee, Y.S., Amadi-Obi, A., Yu, C.R. and Egwuagu, C.E. (2011) Retinal Cells Suppress Intraocular Inflammation (Uveitis) through Production of Interleukin-27 and Interleukin-10. Immunology, 132, 492-502.
[Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Wang, R.X., Yu, C.R., Mahdi, R.M. and Egwuagu, C.E. (2012) Novel IL27p28/IL12p40 Cytokine Suppressed Experimental Autoimmune Uveitis by Inhibiting Autoreactive Th1/Th17 Cells and Promoting Expansion of Regulatory T Cells. Journal of Biological Chemistry, 287, 36012-36021.
[Google Scholar] [CrossRef]
|
|
[23]
|
Gillessen, S., Carvajal, D., Ling, P., Podlaski, F.J., Stremlo, D.L., Familletti, P.C., Gubler, U., Presky, D.H., Stern, A.S. and Gately, M.K. (1995) Mouse Interleukin-12 (IL-12) p40 Homodimer: A Potent IL-12 Antagonist. European Journal of Immunology, 25, 200-206.
[Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Stumhofer, J.S., Tait, E.D., Quinn, W.R., Hosken, N., Spudy, B., Goenka, R., Fielding, C.A., O’Hara, A.C., Chen, Y., Jones, M.L., Saris, C.J., Rose-John, S., Cua, D.J., Jones, S.A., Elloso, M.M., Grotzinger, J., Cancro, M.P., Levin, S.D. and Hunter, C.A. (2010) A Role for IL-27p28 as an Antagonist of gp130-Mediated Signaling. Nature Immunology, 11, 1119-1126.
[Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Collison, L.W., Workman, C.J., Kuo, T.T., Boyd, K., Wang, Y., Vignali, K.M., Cross, R., Sehy, D., Blumberg, R.S. and Vignali, D.A. (2007) The Inhibitory Cytokine IL-35 Contributes to Regulatory T-Cell Function. Nature, 450, 566-569.
[Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Wang, R.X., Yu, C.R., Dambuza, I.M., Mahdi, R.M., Dolinska, M.B., Sergeev, Y.V., Wingfield, P.T., Kim, S.H. and Egwuagu, C.E. (2014) Interleukin-35 Induces Regulatory B Cells That Suppress Autoimmune Disease. Nature Medicine, 20, 633-641.
[Google Scholar] [CrossRef] [PubMed]
|